Interestingly, methylated FOXK2 has been observed in circulating leukocytes of smokers in an epigenome-wide association study of nicotine equivalents (23), suggesting that epigenetic modifications serve as additional mechanisms for silencing FOXK2 gene expression, which may have implications for the pathogenesis of lung cancer. The gene discussed is FOXK2; the disease is lung cancer.